Jazz Pharmaceuticals PLC (JAZZ)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total assets US$ in thousands 12,012,300 12,255,700 11,361,900 11,327,100 11,393,400 11,204,100 11,260,500 11,047,100 10,835,300 10,384,700 11,200,100 11,768,900 12,298,600 12,478,200 13,213,000 6,756,470 6,535,900 6,291,960 6,066,500 5,215,300
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $12,012,300K
= 0.00

The debt-to-assets ratio for Jazz Pharmaceuticals PLC has consistently been 0.00 over the reported periods from March 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its assets during these periods. A debt-to-assets ratio of 0.00 typically suggests that the company is not relying on borrowed funds to support its operations and investments. The company's ability to maintain a low debt-to-assets ratio demonstrates a strong financial position in terms of solvency and financial stability. It indicates that Jazz Pharmaceuticals PLC has been able to fund its operations and investments primarily through equity financing, which may signal a conservative approach to managing its capital structure.